Valuation: Bayer AG

Market Cap 48.46B 55.93B 45.73B 41.49B 77.83B 5,361B 78.4B 546B 210B 2,719B 210B 205B 8,646B P/E 2026 *
22.3x
P/E 2027 * 16.1x
Enterprise Value 78.41B 90.5B 74B 67.13B 126B 8,674B 127B 884B 341B 4,400B 340B 332B 13,989B EV / Sales 2026 *
1.71x
EV / Sales 2027 * 1.6x
Free-Float
99.99%
Yield 2026 *
0.32%
Yield 2027 * 1.13%
1 week+4.51%
Current month+4.51%
1 month+5.41%
3 months+46.76%
6 months+32.53%
Current year+42.93%
1 week 210.5
Extreme 210.5
220
1 month 206.7
Extreme 206.7
220
3 years 78.97
Extreme 78.97
231.65
Manager TitleAgeSince
Chief Executive Officer 60 2023-05-31
Director of Finance/CFO 57 2026-05-31
Chief Tech/Sci/R&D Officer 59 2021-01-31
Director TitleAgeSince
Director/Board Member 56 2012-03-31
Director/Board Member 61 2017-03-31
Chairman 68 2020-04-27
Change 5-day change 1-year change 3-year change Capi.($)
-0.18%+4.51%+85.72%-3.36% 55.93B
+2.02%-0.96%+50.69%+92.40% 1,015B
+0.28%-3.24%+49.57%+62.65% 642B
+1.81%+2.07%+19.89%+70.38% 463B
-0.76%+2.34%+37.75%+37.25% 353B
+0.18%+2.09%+16.87%+23.72% 265B
-0.33%+2.04%+6.17%+10.77% 254B
+1.10%-12.75%+38.03%+45.44% 206B
-0.15%-4.20%-21.22%-58.03% 191B
+1.87%-3.04%+27.81%+89.26% 182B
Average +0.61%-3.35%+31.13%+37.05% 396.69B
Weighted average by Cap. +0.75%-2.21%+34.59%+55.97%

Financials

2026 *2027 *
Net sales 45.78B 52.83B 43.2B 39.19B 73.52B 5,063B 74.05B 516B 199B 2,569B 198B 194B 8,166B 46.99B 54.23B 44.34B 40.23B 75.46B 5,197B 76.01B 530B 204B 2,637B 204B 199B 8,382B
Net income 2.14B 2.47B 2.02B 1.83B 3.44B 237B 3.46B 24.14B 9.3B 120B 9.28B 9.08B 382B 2.94B 3.39B 2.77B 2.52B 4.72B 325B 4.75B 33.11B 12.76B 165B 12.73B 12.45B 524B
Net Debt 29.95B 34.57B 28.27B 25.64B 48.1B 3,313B 48.45B 338B 130B 1,681B 130B 127B 5,343B 26.82B 30.96B 25.31B 22.96B 43.08B 2,967B 43.39B 302B 116B 1,505B 116B 114B 4,785B
Logo Bayer AG
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).
Employees
-
Date Price Change
26-09-15 PLN 219.60 -0.18%
26-09-14 PLN 220.00 0.00%
26-09-11 PLN 220.00 +3.58%
26-09-10 PLN 212.40 +0.90%
26-09-09 PLN 210.50 0.00%
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
49.33EUR
Average target price
58.22EUR
Spread / Average Target
+18.03%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!